Our History
2024
Leader in prescription and sales in Peru.
Deutsche Pharma positions itself as the leader in medical prescriptions and sales within the Peruvian pharmaceutical market, reaffirming its strength, reliability, and commitment to health.
2022
Entry into the Middle Eastern market
Deutsche Pharma expanded its international presence, consolidating its global reach and its commitment to health worldwide.
1986
Launch of Hirudoid® Forte
Una nueva presentación con mayor concentración del principio activo; Poliéster mucopolisacárido del ácido sulfúrico, que busca brindar una solución más intensa y localizada.
1949
Hirudoid® enters the German pharmaceutical market.
Developed in Munich, it stood out for its efficacy in treating bruises and established itself as an essential product in household first-aid kits.
1954
Hirudoid® arrives in the Peruvian market.
Due to its rapid acceptance among doctors and patients, it consolidated its presence in the country, marking the beginning of a solid trajectory based on trust and efficacy.
2008
Rights for Latin America are acquired.
This strategic decision marked the beginning of a new stage of growth, allowing high-quality products to be brought to various markets across the Latin American continent.
1879
The origins of our history
For four generations, Deutsche Pharma has cared for the health and well-being of Peruvian families with effective products of international quality.